hubtechinsider.wordpress.com
BioAssets Development, a Wellesley based investigator of spinal applications for existing drugs, enters into $30 Million option to be acquired by Cephalon
BioAssets Development, a Wellesley based investigator of spinal applications for existing drugs, enters into $30 Million option to be acquired by Cephalon